SAN

82.48

-0.46%↓

UCB

265.3

-0.97%↓

SHL.DE

35.94

-1.21%↓

ARGX

645.6

+0.47%↑

VIE

33.34

+0.33%↑

SAN

82.48

-0.46%↓

UCB

265.3

-0.97%↓

SHL.DE

35.94

-1.21%↓

ARGX

645.6

+0.47%↑

VIE

33.34

+0.33%↑

SAN

82.48

-0.46%↓

UCB

265.3

-0.97%↓

SHL.DE

35.94

-1.21%↓

ARGX

645.6

+0.47%↑

VIE

33.34

+0.33%↑

SAN

82.48

-0.46%↓

UCB

265.3

-0.97%↓

SHL.DE

35.94

-1.21%↓

ARGX

645.6

+0.47%↑

VIE

33.34

+0.33%↑

SAN

82.48

-0.46%↓

UCB

265.3

-0.97%↓

SHL.DE

35.94

-1.21%↓

ARGX

645.6

+0.47%↑

VIE

33.34

+0.33%↑

Search

Vetoquinol SA

Uždarymo kaina

SektoriusSveikatos priežiūra

77.4 -1.28

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

77.3

Max

77.7

Pagrindiniai rodikliai

By Trading Economics

Pajamos

25M

Pardavimai

10M

268M

P/E

Sektoriaus vid.

15.431

56.063

Dividendų pajamingumas

1.13

Pelno marža

9.734

Darbuotojai

2,497

EBITDA

252M

301M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+40.49% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.13%

2.45%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-3.5M

931M

Ankstesnė atidarymo kaina

78.68

Ankstesnė uždarymo kaina

77.4

Naujienos nuotaikos

By Acuity

50%

50%

154 / 349 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bearish Evidence

Vetoquinol SA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-03 04:27; UTC

Svarbiausios naujienos

Singapore PM Warns That Fallout From Mideast War Could Outlast Conflict

2026-04-03 20:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-04-03 18:30; UTC

Svarbiausios naujienos

An F15-E Just Went Down in Iran. What to Know About the $30 Million Jet. -- Barrons.com

2026-04-03 18:14; UTC

Rinkos pokalbiai

Eli Lilly Seen as Possible GLP-1 Leader With New Pill Approval -- Market Talk

2026-04-03 17:50; UTC

Rinkos pokalbiai

Microsoft's AI Development Will Weigh on Near-Term Azure Growth -- Market Talk

2026-04-03 17:44; UTC

Įsigijimai, susijungimai, perėmimai

SBA Stock Just Had a Big Day. Why It's Suddenly Hot. -- Barrons.com

2026-04-03 16:50; UTC

Svarbiausios naujienos

An F15-E Just Went Down in Iran. What to Know About the $90 Million Jet. -- Barrons.com

2026-04-03 16:20; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-04-03 16:12; UTC

Uždarbis

Oil Stocks Look Tapped Out. Why It's Time to Move Into Other Sectors. -- Barrons.com

2026-04-03 15:56; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Crypto Markets May Be Active Over Holiday Weekend -- Market Talk

2026-04-03 15:56; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Global Equities Roundup: Market Talk

2026-04-03 15:56; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Global Forex and Fixed Income Roundup: Market Talk

2026-04-03 15:20; UTC

Svarbiausios naujienos

Berkshire, Travelers Join U.S. Plan to Insure Shippers in the Hormuz Strait -- Barrons.com

2026-04-03 15:08; UTC

Įsigijimai, susijungimai, perėmimai

OpenAI Makes Surprise Media Acquisition Ahead of IPO. Why It Will Fail. -- Barrons.com

2026-04-03 14:11; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Oil Shock From War in Iran May Show Up In 2Q Job Growth Data -- Market Talk

2026-04-03 12:56; UTC

Rinkos pokalbiai

Treasury Yields, Dollar Higher Following Robust March Hiring -- Market Talk

2026-04-03 08:20; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-04-03 08:01; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-04-03 08:01; UTC

Rinkos pokalbiai

Meituan's Profitability Likely to Improve This Year -- Market Talk

2026-04-03 07:45; UTC

Rinkos pokalbiai

LG Electronics Could Post Above-Consensus 1Q Earnings -- Market Talk

2026-04-03 06:17; UTC

Rinkos pokalbiai

Naver Likely to Post Below-Consensus 1Q Earnings -- Market Talk

2026-04-03 06:17; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-04-03 04:33; UTC

Rinkos pokalbiai

China Merchants Port Earnings Likely to Recover This Year -- Market Talk

2026-04-03 04:33; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-04-03 04:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2026-04-03 04:01; UTC

Rinkos pokalbiai

Posco Holdings 1Q Earnings Could Fall Short of Expectations -- Market Talk

2026-04-03 02:01; UTC

Rinkos pokalbiai

India Consumer-Staple Companies Likely to Post Broadly Steady 4Q Results -- Market Talk

2026-04-03 01:59; UTC

Rinkos pokalbiai

Sea's Shopee E-Commerce Platform Likely in Reinvestment Phase -- Market Talk

2026-04-03 01:44; UTC

Rinkos pokalbiai

Samsung Likely to Report Record Quarterly Earnings in 2026 -- Market Talk

2026-04-03 01:22; UTC

Rinkos pokalbiai

Dollar Could Hit 160 Yen in Thin Holiday Trading -- Market Talk

Akcijų palyginimas

Kainos pokytis

Vetoquinol SA Prognozė

Kainos tikslas

By TipRanks

40.49% į viršų

12 mėnesių prognozė

Vidutinis 110 EUR  40.49%

Aukščiausias 110 EUR

Žemiausias 110 EUR

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Vetoquinol SA kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

1

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

72.6 / 75.1Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

154 / 349 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
help-icon Live chat